Endurance of COVID 19 in wastewater, natural prescription and antiviral medication for the analysis of COVID 19 and its effects on the development of new antiseptic strategies

*Adelodun, 2020, Snowballing transmission of COVID-19 (SARS-CoV-2) through wastewater: Any sustainable preventive measures to curtail the scourge in low-income countries?, Sci. Total Environ., 742 Bhowmick, 2020, Coronavirus disease 2019 (COVID-19) outbreak: some serious consequences with urban and rural water cycle, npj Clean Water, 3, 10.1038/s41545-020-0079-1 Cahill, 2020, Recreational waters – A potential transmission route for SARS-CoV-2 to humans?, Sci. Total Environ., 740, 10.1016/j.scitotenv.2020.140122 Caoa, 2020, Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence, Travel Med. Infect. Dis., 35 *Carraturo, 2020, Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces, Environ. Pollut., 265 Chaudhry, 2020, Coronavirus Disease 2019 (COVID-19): a new challenge in untreated wastewater, Can. J. Civ. Eng., 00, 1 *Chen, 2020, Janus sword actions of chloroquine and hydroxychloroquine against COVID-19, Cell. Signal., 73 Chen, 2020, Protection against COVID-19 injury by qingfei paidu decoction via antiviral, anti-inflammatory activity and metabolic programming, Biomed. Pharmacother., 129, 110281, 10.1016/j.biopha.2020.110281 Chen, 2020, Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial, Medrxiv Choudhary, 2020, Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance, New Microbes New Infect., 35, 10.1016/j.nmni.2020.100684 Darnella, 2005, Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV, J. Virol. Methods, 121, 85, 10.1016/j.jviromet.2004.06.006 Fan, 2020, COVID-19 drug treatment in China, Curr. Pharmacol. Rep., 6, 146, 10.1007/s40495-020-00218-5 Farkas, 2020, Wastewater and public health: the potential of wastewater surveillance for monitoring COVID-19, Curr. Opin. Environ. Sci. Health, 17, 14, 10.1016/j.coesh.2020.06.001 Geller, 2012, Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies, Viruses, 4, 3044, 10.3390/v4113044 Ghernaout, 2020, Urgent proposals for disinfecting hospital wastewaters during COVID-19 Pandemic, Open Access Library J., 07, 1 Gonzalez, 2020, COVID-19 surveillance in Southeastern Virginia using wastewater-based epidemiology, Water Res., 186, 116296, 10.1016/j.watres.2020.116296 Grein, 2020, Compassionate use of remdesivir for patients with severe Covid-19, N. Engl. J. Med., 382, 2327, 10.1056/NEJMoa2007016 Gupta, 2020, Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome, Indian J. Med. Res., 152, 149, 10.4103/ijmr.IJMR_2785_20 Han, 2021, COVID-19 pandemic crisis and food safety: Implications and inactivation strategies, Trends Food Sci. Technol., 109, 25, 10.1016/j.tifs.2021.01.004 Hill, 2020, Minimum costs to manufacture new treatments for COVID-19, J. Virus Eradicat., 6, 61, 10.1016/S2055-6640(20)30018-2 Hong-Zhi, 2020, Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP), Chin. J. Nat. Med., 18, 206 Huang, 2020, Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19), Pharmacol. Res., 158, 10.1016/j.phrs.2020.104939 Hung, 2020, Recent progress on the traditional Chinese medicines that regulate the blood, J. Food Drug Anal., 24, 221, 10.1016/j.jfda.2015.10.009 Jean, 2020, Treatment options for COVID-19: the reality and challenges, J. Microbiol. Immunol. Infect., 53, 436, 10.1016/j.jmii.2020.03.034 *Jin, 2020, Drug treatment of coronavirus disease 2019 (COVID-19) in China, Eur. J. Pharmacol., 883, 173326, 10.1016/j.ejphar.2020.173326 Kitajima, 2020, SARS-CoV-2 in wastewater: State of the knowledge and research needs, Sci. Total Environ., 739, 10.1016/j.scitotenv.2020.139076 Lee, 2020, A consensus guideline of herbal medicine for coronavirus disease 2019, Integ. Med. Res., 9, 100470, 10.1016/j.imr.2020.100470 Ling, 2020, Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2), J. Integ. Med., 18, 87, 10.1016/j.joim.2020.02.004 *Lorenzo, 2019, Wastewater-based epidemiology: current status and future prospects, Curr. Opin. Environ. Sci. Health, 9, 77, 10.1016/j.coesh.2019.05.007 *Lu, 2020, Primary concentration – The critical step in implementing the wastewater-based epidemiology for the COVID-19 pandemic: A mini-review, Sci. Total Environ., 747 Lyu, 2021, Traditional Chinese medicine in COVID-19, Acta Pharm. Sin. B, 11, 3337, 10.1016/j.apsb.2021.09.008 Marcelo Souza de Assis, 2020, Safety alert for hospital environments and health professional: chlorhexidine is ineffective for coronavirus, Revista da Associação Médica Brasileira, 66 Maurya, 2020, Therapeutic Development and Drugs for the Treatment of COVID-19, 109 McClellan, 2020, Oseltamivir A review of its use in influenza, ADIS Drug Eval., 61, 263 *Meda Venkatasubbaiah, 2020, Literature-based review of the drugs used for the treatment of COVID19, Curr. Med. Res. Pract., 10, 100, 10.1016/j.cmrp.2020.05.013 *Mirzaie, 2020, A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19), Complement. Therap. Clin. Practice, 40 Muthu Kumara Pandian, 2022, Potential risks and approaches to reduce the toxicity of disinfection by-product – A review, Sci. Total Environ., 822, 153323, 10.1016/j.scitotenv.2022.153323 Polo, 2020, Making waves: Wastewater-based epidemiology for COVID-19 – approaches and challenges for surveillance and prediction, Water Res., 186, 10.1016/j.watres.2020.116404 Rai, 2021, Detection technologies and recent developments in the diagnosis of COVID-19 infection, Appl. Microbiol. Biotechnol., 105, 441, 10.1007/s00253-020-11061-5 *Randazzo, 2020, SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area, Water Res., 181 Ren, 2020, Traditional Chinese medicine for COVID-19 treatment, Pharmacol. Res., 155 Singh, 2021, Detection and disinfection of COVID-19 virus in wastewater, Environ. Chem., 19, 1917 *Sun, 2020, Remdesivir for Treatment of COVID-19: combination of pulmonary and IV administration may offer aditional benefit, AAPS J., 22, 77, 10.1208/s12248-020-00459-8 Susan Amiriana, 2020, Current knowledge about the antivirals remdesivir (GS-5734) and GS441524 as therapeutic options for coronaviruses, One Health, 9 Tong, 2020, The potential insights of Traditional Chinese Medicine on treatment of COVID-19, Chin. Med., 15, 51, 10.1186/s13020-020-00326-w Torequl Islam, 2020, A perspective on emerging therapeutic interventions for COVID-19, Front. Public Health, 8, 10.3389/fpubh.2020.00281 Tran, 2020, SARS-CoV-2 coronavirus in water and wastewater: A critical review about presence and concern, Environ. Res., 193 Unhale, 2020, A REVIEW ON CORONA VIRUS (COVID-19), Internat. J. Pharm. Life Sci., 6, 109 *Vellingiri, 2020, COVID-19: A promising cure for the global panic, Sci. Total Environ., 725, 138277, 10.1016/j.scitotenv.2020.138277 *Venugopal, 2020, Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots, Curr. Opin. Environ. Sci. Health, 17, 8, 10.1016/j.coesh.2020.05.003 Vijayvargiya, 2020, Treatment considerations for COVID-19: A critical review of the evidence, Mayo Clin. Proc., 95, 1454, 10.1016/j.mayocp.2020.04.027 Wang, 2020, Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China, Environ. Pollut., 262, 114665, 10.1016/j.envpol.2020.114665 *Wen, 2020, Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication, J. Trad. Complement. Med., 1, 41 Whitley, 2001, Oral oseltamivir treatment of influenza in children, Pediatr. Infect. Dis. J., 20, 127, 10.1097/00006454-200102000-00002 Wu, 2020, An update on current therapeutic drugs treating COVID-19, Curr. Pharmacol. Rep., 1 *Xu, 2020, Traditional Chinese Medicine treatment of COVID-19, Complement. Therap. Clin. Practice, 39 Yang, 2020, COVID-19: immunopathogenesis and immunotherapeutics, Signal Transduct. Target. Therapy, 5, 128, 10.1038/s41392-020-00243-2 Yang, 2022, Traditional Chinese medicine against COVID-19: Role of the gut microbiota, Biomed. Pharmacother., 149, 10.1016/j.biopha.2022.112787 Younis, 2020, Hydroxychloroquine in COVID-19 patients: pros and cons, Front. Pharmacol., 11, 10.3389/fphar.2020.597985 Zhai, 2020, The epidemiology, diagnosis and treatment of COVID-19, Int. J. Antimicrob. Agents, 55, 105955, 10.1016/j.ijantimicag.2020.105955